13D/G large-stake feed

Latest 13D/G Reports

Since 05 May 2026. Review filer CIK, subject security, ownership %, and SEC evidence first.

Recent 13D/G signals

Large-stake disclosures to inspect

Start with holder, issuer/security, stake size, and SEC evidence.

13G/A

BIOTECHNOLOGY VALUE FUND L P stake in Monte Rosa Therapeutics, Inc.

Holder CIK 0000918923

13G/A GLUE
CIK
0000918923
Issuer
Monte Rosa Therapeutics, Inc.
Security
GLUE
Source
SEC 13G/A
Action
Beneficial ownership disclosure
Magnitude
6.3% / 5,085,886 shares
Filed
15 May 2026, 16:10:29 UTC

Check whether this is a new stake, an amended position, or a material ownership change before moving to the issuer page.

13D/A

Kaufman Kapital LLC stake in BranchOut Food Inc.

Holder CIK 0002033227

13D/A BOF
CIK
0002033227
Issuer
BranchOut Food Inc.
Security
BOF
Source
SEC 13D/A
Action
Beneficial ownership disclosure
Magnitude
11% / 1,689,676 shares
Filed
15 May 2026, 16:10:28 UTC

Check whether this is a new stake, an amended position, or a material ownership change before moving to the issuer page.

13G/A

S.H.N. Financial Investments Ltd. stake in Actelis Networks Inc

Holder CIK 0001890802

13G/A ASNS
CIK
0001890802
Issuer
ACTELIS NETWORKS INC
Security
ASNS
Source
SEC 13G/A
Action
Beneficial ownership disclosure
Magnitude
3% / 812,500 shares
Filed
15 May 2026, 16:10:12 UTC

Check whether this is a new stake, an amended position, or a material ownership change before moving to the issuer page.

13G/A

DISCIPLINED GROWTH INVESTORS INC /MN stake in Core Laboratories Inc. /DE/

Holder CIK 0001050442

13G/A CLB
CIK
0001050442
Issuer
Core Laboratories Inc. /DE/
Security
CLB
Source
SEC 13G/A
Action
Beneficial ownership disclosure
Magnitude
11% / 4,937,115 shares
Filed
15 May 2026, 16:10:12 UTC

Check whether this is a new stake, an amended position, or a material ownership change before moving to the issuer page.

13G

CANADA PENSION PLAN INVESTMENT BOARD stake in SM Energy Co

Holder CIK 0001283718

13G SM
CIK
0001283718
Issuer
SM Energy Co
Security
SM
Source
SEC 13G
Action
Beneficial ownership disclosure
Magnitude
6.1% / 14,493,791 shares
Filed
15 May 2026, 16:10:02 UTC

Check whether this is a new stake, an amended position, or a material ownership change before moving to the issuer page.

13G/A

CANADA PENSION PLAN INVESTMENT BOARD stake in Netskope Inc

Holder CIK 0001283718

13G/A NTSK
CIK
0001283718
Issuer
Netskope Inc
Security
NTSK
Source
SEC 13G/A
Action
Beneficial ownership disclosure
Magnitude
3.7% / 8,960,263 shares
Filed
15 May 2026, 16:10:02 UTC

Check whether this is a new stake, an amended position, or a material ownership change before moving to the issuer page.

Rows shown
1,051-1,100 of 3,979
Per page
50
Current page
22

Schedule 13D/G ownership events

Activist and large-stake radar

Stake size, change direction, reporting filer, issuer, active/passive form type, and SEC evidence.

Visible reports

6

Fresh large-stake filings promoted above the legacy table.

13D/13G mix

1/5

Active-intent candidates versus passive large-stake disclosures.

Largest visible stake

11%

Highest class ownership surfaced in the preview cards.

Newest evidence

15 May 2026

Use recency before treating an old large-stake story as fresh.

Signal checks

13D active-intent check

active/control intent, item text, amendments

13G passive stake check

large passive holder disclosure

Stake change direction

ownership percent and share change

Issuer and owner follow-up

issuer, filer history, insider activity, 13F context

SEC-verifiable Schedule 13D/G path

Open the Schedule 13D/G filing, then cross-check insider and Form 13F evidence.

Large-stake signal

BIOTECHNOLOGY VALUE FUND L P

Monte Rosa Therapeutics, Inc. (GLUE)

Schedule 13G/A Ownership 6.3% Filing-backed
CIK
000092189526001394
Source
SEC Schedule 13G/A
Action
Large stake increase disclosed
Magnitude
6.3%
Filed
15 May 2026, 16:10:29 UTC
Period
31 Mar 2026

BIOTECHNOLOGY VALUE FUND L P filed Schedule 13G/A for Monte Rosa Therapeutics, Inc. (GLUE). Reported class ownership: 6.3%. Ownership change: +0.4%. Share change: +33%. Open the SEC evidence before treating this as an activist or passive large-stake signal.

Create an account from this card and we will save this large-stake filer to your watchlist after sign-in or verification.

Large-stake signal

Kaufman Kapital LLC

BranchOut Food Inc. (BOF)

Schedule 13D/A Ownership 11% Filing-backed
CIK
000109991026000185
Source
SEC Schedule 13D/A
Action
Potential activist/control stake disclosed
Magnitude
11%
Filed
15 May 2026, 16:10:28 UTC
Period
12 May 2026

Kaufman Kapital LLC filed Schedule 13D/A for BranchOut Food Inc. (BOF). Reported class ownership: 11%. Ownership change: -22%. Share change: -74%. Open the SEC evidence before treating this as an activist or passive large-stake signal.

Create an account from this card and we will save this large-stake filer to your watchlist after sign-in or verification.

Large-stake signal

S.H.N. Financial Investments Ltd.

Actelis Networks Inc (ASNS)

Schedule 13G/A Ownership 3% Filing-backed
CIK
000155335026000084
Source
SEC Schedule 13G/A
Action
Large beneficial ownership stake disclosed
Magnitude
3%
Filed
15 May 2026, 16:10:12 UTC
Period
15 May 2026

S.H.N. Financial Investments Ltd. filed Schedule 13G/A for Actelis Networks Inc (ASNS). Reported class ownership: 3%. Open the SEC evidence before treating this as an activist or passive large-stake signal.

Create an account from this card and we will save this large-stake filer to your watchlist after sign-in or verification.

Large-stake signal

DISCIPLINED GROWTH INVESTORS INC /MN

Core Laboratories Inc. /DE/ (CLB)

Schedule 13G/A Ownership 11% Filing-backed
CIK
000105044226000014
Source
SEC Schedule 13G/A
Action
Large stake reduction disclosed
Magnitude
11%
Filed
15 May 2026, 16:10:12 UTC
Period
31 Mar 2026

DISCIPLINED GROWTH INVESTORS INC /MN filed Schedule 13G/A for Core Laboratories Inc. /DE/ (CLB). Reported class ownership: 11%. Ownership change: -0.4%. Share change: -4.4%. Open the SEC evidence before treating this as an activist or passive large-stake signal.

Create an account from this card and we will save this large-stake filer to your watchlist after sign-in or verification.

Large-stake signal

CANADA PENSION PLAN INVESTMENT BOARD

SM Energy Co (SM)

Schedule 13G Ownership 6.1% Filing-backed
CIK
000119312526226707
Source
SEC Schedule 13G
Action
Large beneficial ownership stake disclosed
Magnitude
6.1%
Filed
15 May 2026, 16:10:02 UTC
Period
31 Mar 2026

CANADA PENSION PLAN INVESTMENT BOARD filed Schedule 13G for SM Energy Co (SM). Reported class ownership: 6.1%. Open the SEC evidence before treating this as an activist or passive large-stake signal.

Create an account from this card and we will save this large-stake filer to your watchlist after sign-in or verification.

Large-stake signal

CANADA PENSION PLAN INVESTMENT BOARD

Netskope Inc (NTSK)

Schedule 13G/A Ownership 3.7% Filing-backed
CIK
000119312526226708
Source
SEC Schedule 13G/A
Action
Large beneficial ownership stake disclosed
Magnitude
3.7%
Filed
15 May 2026, 16:10:02 UTC
Period
31 Mar 2026

CANADA PENSION PLAN INVESTMENT BOARD filed Schedule 13G/A for Netskope Inc (NTSK). Reported class ownership: 3.7%. Open the SEC evidence before treating this as an activist or passive large-stake signal.

Create an account from this card and we will save this large-stake filer to your watchlist after sign-in or verification.

Filed by Symbol Subject Shares owned Ownership % Source
BIOTECHNOLOGY VALUE FUND L P CIK 0000918923 GLUE Monte Rosa Therapeutics, Inc. 5,085,886 6.3% SEC filing
Kaufman Kapital LLC CIK 0002033227 BOF BranchOut Food Inc. 1,689,676 11% SEC filing
S.H.N. Financial Investments Ltd. CIK 0001890802 ASNS Actelis Networks Inc 812,500 3% SEC filing
DISCIPLINED GROWTH INVESTORS INC /MN CIK 0001050442 CLB Core Laboratories Inc. /DE/ 4,937,115 11% SEC filing
CANADA PENSION PLAN INVESTMENT BOARD CIK 0001283718 SM SM Energy Co 14,493,791 6.1% SEC filing
CANADA PENSION PLAN INVESTMENT BOARD CIK 0001283718 NTSK Netskope Inc 8,960,263 3.7% SEC filing
CANADA PENSION PLAN INVESTMENT BOARD CIK 0001283718 COLD Americold Realty Trust, Inc. 14,726,365 5.2% SEC filing
CF Series DAT A LP CIK 0002084744 ORBS Eightco Holdings Inc. 22,958,143 6.1% SEC filing
MPM BioImpact LLC CIK 0001687078 DBVT DBV TECHNOLOGIES S.A. 26,066,806 8.8% SEC filing
BIOTECHNOLOGY VALUE FUND L P CIK 0000918923 FHTX Foghorn Therapeutics Inc. 5,866,613 10% SEC filing
Greenhouse Funds LLLP CIK 0001626220 VYX NCR Voyix Corporation 22,431,714 16% SEC filing
Rubric Capital Management LP CIK 0001687509 ZYME Zymeworks Inc. 7,000,000 9.5% SEC filing
Portolan Capital Management, LLC CIK 0001350290 VPG Vishay Precision Group, Inc. 1,019,868 8.3% SEC filing
MPM BioImpact LLC CIK 0001687078 FBRX Forte Biosciences, Inc. 1,000,682 7.2% SEC filing
HARRIS ASSOCIATES L P CIK 0000813917 CRBG Corebridge Financial, Inc. 24,964,260 5.2% SEC filing
Gates Capital Management, Inc. CIK 0001312908 TIC TIC Solutions, Inc. 21,850,000 9.9% SEC filing
Rubric Capital Management LP CIK 0001687509 SPRY ARS Pharmaceuticals, Inc. 8,000,000 8.1% SEC filing
BIOTECHNOLOGY VALUE FUND L P CIK 0000918923 FDMT 4D Molecular Therapeutics, Inc. 5,346,519 10% SEC filing
Dimension Capital II, L.P. CIK 0002040933 ODTX Odyssey Therapeutics, Inc. 3,333,516 7.1% SEC filing
PROPPER KERRY CIK 0001282327 CAPN Cayson Acquisition Corp. 0 0% SEC filing
Rubric Capital Management LP CIK 0001687509 SDGR Schrodinger, Inc. 6,000,000 9.3% SEC filing
Rubric Capital Management LP CIK 0001687509 PRTA PROTHENA CORPORATION PUBLIC LIMITED COMPANY 5,000,000 9.3% SEC filing
Portolan Capital Management, LLC CIK 0001350290 REAX Real Brokerage Inc 14,519,848 6.8% SEC filing
Andreessen Horowitz Fund IV, L.P. CIK 0001603198 OMDA Omada Health, Inc. 2,461,709 4.2% SEC filing
BIOTECHNOLOGY VALUE FUND L P CIK 0000918923 ELDN Eledon Pharmaceuticals, Inc. 7,868,419 10% SEC filing
Rubric Capital Management LP CIK 0001687509 NFE New Fortress Energy Inc. 0 0% SEC filing
Commodore Capital LP CIK 0001831942 ANRO Alto Neuroscience, Inc. 3,588,180 9.9% SEC filing
BIOTECHNOLOGY VALUE FUND L P CIK 0000918923 CMPX Compass Therapeutics, Inc. 7,764,842 4.3% SEC filing
Jericho Capital Asset Management L.P. CIK 0001525234 LION Lionsgate Studios Corp. 18,815,105 6.5% SEC filing
Portolan Capital Management, LLC CIK 0001350290 QTRX Quanterix Corp 2,945,823 6.2% SEC filing
5AM Partners VII, LLC CIK 0001873545 SRZN Surrozen, Inc. 1,162,500 9.5% SEC filing
HBM Healthcare Investments (Cayman) Ltd. CIK 0001232258 ALXO ALX ONCOLOGY HOLDINGS INC 8,590,692 6.5% SEC filing
BIOTECHNOLOGY VALUE FUND L P CIK 0000918923 CGEM Cullinan Therapeutics, Inc. 6,161,469 10% SEC filing
Soroban Capital Partners LP CIK 0001517857 DPZ Domino's Pizza Inc. 2,495,194 7.4% SEC filing
Greenhouse Funds LLLP CIK 0001626220 NEO NEOGENOMICS, INC. 9,215,903 7.1% SEC filing
CITY OF LONDON INVESTMENT MANAGEMENT CO LTD CIK 0001034546 TWN Taiwan Fund Inc 2,240,059 40% SEC filing
GATE CITY CAPITAL MANAGEMENT, LLC CIK 0001705447 IPI Intrepid Potash Inc. 224,275 1.7% SEC filing
GATE CITY CAPITAL MANAGEMENT, LLC CIK 0001705447 JAKK JAKKS Pacific, Inc. 967,114 8.5% SEC filing
LONE PINE CAPITAL LLC CIK 0001061165 WING Wingstop Inc. 0 0% SEC filing
GATE CITY CAPITAL MANAGEMENT, LLC CIK 0001705447 SEG Seaport Entertainment Group Inc. 689,447 5.4% SEC filing
Endure Capital Management, LLC CIK 0002055657 PAX Patria Investments Limited 6,360,930 9.3% SEC filing
HARRIS ASSOCIATES L P CIK 0000813917 CNH CNH Industrial N.V. 58,127,119 4.7% SEC filing
Wallinger Dirk CIK 0002100113 YSS York Space Systems Inc. 11,168,593 8.6% SEC filing
HG Vora Capital Management, LLC CIK 0001525362 NLCP NewLake Capital Partners, Inc. 1,615,000 7.8% SEC filing
CITY OF LONDON INVESTMENT MANAGEMENT CO LTD CIK 0001034546 TDF TEMPLETON DRAGON FUND INC 8,937,505 36% SEC filing
FIG Buyer GP, LLC CIK 0002024046 NN NextNav Inc. 22,058,944 15% SEC filing
Goldsteen Mitchell B. CIK 0001997607 SHIM Shimmick Corporation 20,974,873 58% SEC filing
Kirban Michael CIK 0001890258 COCO The Vita Coco Company, Inc. 3,274,866 5.6% SEC filing
BRC S.a.R.L. CIK 0001301486 BUD Anheuser-Busch InBev SA/NV 1,031,561,286 52% SEC filing
Euclidean Capital LLC CIK 0001825034 PMVP PMV Pharmaceuticals, Inc. 2,627,643 4.9% SEC filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .